Patents by Inventor Mark Denison

Mark Denison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10551814
    Abstract: Generic shadowing allows a shadowing device in a process plant to automatically discover, without pre-configuration or pre-definition, and without the use of a configuration tool, source control objects that are hosted at other devices and that are to be shadowed. Source control objects may utilize any data type, format, structure, language, etc. The shadowing device includes a shadow manager and a set of primitive components defining simple data types that are utilized to discover the configurations/definitions and data types of source control objects, and includes a shadow library in which signatures of discovered source control objects are stored. Signatures are instantiated and used by the shadowing device to provide dynamic data to recipient devices, applications, and/or control objects in the process control system, where the dynamic data is a mirror of data that is observed first-hand by the source control objects during their on-line operations at their host devices.
    Type: Grant
    Filed: July 20, 2017
    Date of Patent: February 4, 2020
    Assignee: FISHER-ROSEMOUNT SYSTEMS, INC.
    Inventors: Godfrey R. Sherriff, Gary Law, David Mark Smith, David R. Denison, Brandon Hieb
  • Patent number: 7452542
    Abstract: The present invention is directed live, attenuated coronavirus vaccines. The vaccine comprises a viral genome encoding a p59 protein having at mutation at a specific tyrosine residue, and may include other attenuating mutations. Such viruses show reduced growth and pathogenicity in vivo.
    Type: Grant
    Filed: May 23, 2005
    Date of Patent: November 18, 2008
    Assignee: Vanderbilt University
    Inventor: Mark Denison
  • Publication number: 20070286872
    Abstract: The present invention is directed live, attenuated Nidovirus vaccines, and in a particular embodiment, to coronavirus vaccines. The vaccine comprises a viral genome encoding a replicase polyprotein having at least one proteinase cleavage site that exhibits reduced or no cleavage. Such viruses show reduced.
    Type: Application
    Filed: April 22, 2004
    Publication date: December 13, 2007
    Applicant: Vanderbilt University
    Inventor: Mark Denison
  • Publication number: 20060039926
    Abstract: The present invention is directed live, attenuated coronavirus vaccines. The vaccine comprises a viral genome encoding a p59 protein having at mutation at a specific tyrosine residue, and may include other attenuating mutations. Such viruses show reduced growth and pathogenicity in vivo.
    Type: Application
    Filed: May 23, 2005
    Publication date: February 23, 2006
    Inventor: Mark Denison
  • Patent number: 5368993
    Abstract: The present invention relates to photoresists particularly suitable for deep U.V. exposure and having the capability of forming highly resolved features. The invention is characterized by use of a resist resin binder that comprises a nonaromatic cyclic alcohol-phenol copolymer that has a relatively low molecular weight and narrow distribution of molecular weight and cyclic alcohol concentration.
    Type: Grant
    Filed: April 15, 1994
    Date of Patent: November 29, 1994
    Assignee: Shipley Company Inc.
    Inventors: James W. Thackeray, Mark Denison, George W. Orsula
  • Patent number: 5340696
    Abstract: The present invention relates to photoresists particularly suitable for deep U.V. exposure and having the capability of forming highly resolved features. The invention is characterized by use of a resist resin binder that comprises a nonaromatic cyclic alcohol-phenol copolymer that has a relatively low molecular weight and narrow distribution of molecular weight and cyclic alcohol concentration.
    Type: Grant
    Filed: January 29, 1993
    Date of Patent: August 23, 1994
    Assignee: Shipley Company Inc.
    Inventors: James W. Thackeray, Mark Denison, George W. Orsula